EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of Notch signalling and its crosstalk with oestrogen receptor signalling in breast cancer

Aygun Azadova, Orkhan Isayev, Antonio Marco, Greg N Brooke

Cancer and Metastasis Reviews · 2026

DOI: 10.1007/s10555-026-10331-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer and Metastasis Reviews, 2026. Verfasst von Aygun Azadova und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, UK. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Notch, Receptors, Estrogen, Estrogen Receptor alpha. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Azerbaijani Government Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BCa) is the most frequently diagnosed malignancy in women worldwide, with approximately 70% of cases driven by oestrogen receptor alpha (ERα). Endocrine therapies aim to suppress ERα signalling activity and form the foundation of current therapeutic strategies. However, a substantial proportion of patients either fail to respond due to intrinsic resistance or acquire resistance over the course of the treatment. This resistance arises through a complex interplay of factors including crosstalk with other signalling pathways such as Notch. Notch signalling, essential for mammary gland development, is aberrantly activated in breast tumours, where it contributes to cancer stem cell maintenance, epithelial-mesenchymal transition, angiogenesis, and metastasis. Notch receptors exert context- and subtype-specific roles: Notch1 and 4 promote tumour aggressiveness, whereas Notch2 often exhibits tumour-suppressive roles. In ERα-positive BCa, ERα and Notch signalling cooperate to drive resistance, whereas in ERα-negative disease, Notch promotes stemness and angiogenesis. While anti-oestrogen therapies effectively inhibit tumour growth, they can paradoxically activate Notch signalling and promote therapeutic resistance. Co-targeting Notch alongside endocrine therapy has been proposed as a strategy to delay the onset of therapeutic resistance. However, clinical development of Notch inhibitors has been limited by toxicity associated with pan-Notch blockade. More selective approaches, such as paralogue-specific antibodies, transcription-complex disruption, rational drug combinations, and advanced delivery platforms, are under active development to overcome these limitations. This review outlines the ERα-Notch crosstalk in BCa and examines current and emerging strategies for targeting Notch to overcome endocrine resistance and improve clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, NotchReceptors, EstrogenEstrogen Receptor alphaHumansFemaleSignal TransductionAnimalsReceptor Cross-TalkDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Breast cancerCrosstalkEndocrine resistanceEndocrine therapyNotchNotch inhibitorsOestrogen receptor

Substanzen

Receptors, NotchReceptors, EstrogenEstrogen Receptor alpha

Autor:innen und Institutionen

  • School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, UK.
  • Department of Cytology, Embryology, and Histology, Azerbaijan Medical University, Baku, AZ1022, Azerbaijan.
  • School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, UK. gbrooke@essex.ac.uk.

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Azerbaijani Government Scholarship

Zitieren

APA

Azadova, A., Isayev, O., Marco, A., & Brooke, G. N. (2026). The role of Notch signalling and its crosstalk with oestrogen receptor signalling in breast cancer. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-026-10331-4

Vancouver

Azadova A, Isayev O, Marco A, Brooke GN. The role of Notch signalling and its crosstalk with oestrogen receptor signalling in breast cancer. Cancer and Metastasis Reviews. 2026. doi:10.1007/s10555-026-10331-4

BibTeX
@article{Azadova2026,
  author = {Azadova, Aygun and Isayev, Orkhan and Marco, Antonio and Brooke, Greg N},
  title = {The role of Notch signalling and its crosstalk with oestrogen receptor signalling in breast cancer},
  journal = {Cancer and Metastasis Reviews},
  year = {2026},
  doi = {10.1007/s10555-026-10331-4}
}
Kostenlos starten →